Zobrazeno 1 - 10
of 13
pro vyhledávání: '"A. R. Lussow"'
Autor:
Philippe Pouletty, Roland Buelow, Alexander R. Lussow, Laurent Fanget, Lan Gao, Matthew S. Block
Publikováno v:
Transplantation. 62:1703-1708
Antihapten antibodies binding to ligand-hapten conjugates are able to mediate complement mediated lysis in vitro. Based on this observation we propose a new in vivo immunotherapy using molecules that combine a low molecular weight hapten binding to a
Publikováno v:
Journal of Immunotherapy. 19:257-265
The elimination of cell populations in vivo often relies on reagents that are self-limiting, are difficult to design and produce or contain highly toxic components. Here we describe a novel immunotherapy using molecules that combine a cell-specific l
Autor:
H. Robson MacDonald, A R Lussow
Publikováno v:
European Journal of Immunology. 24:445-449
The in vitro T cell nonresponsiveness or anergy to restimulation with staphylococcal enterotoxin B (SEB) following the in vivo injection of the superantigen is well characterized. Here we use mice transgenic for a V beta 8.2+ T cell receptor (TcR) (r
Publikováno v:
Immunological Reviews. 133:105-117
Publikováno v:
International Immunology. 5:55-61
Reactivity of murine T cells with viral or bacterial superantigens is clearly correlated with the expression of TCR V beta domains. Thus, T cells responding to the minor lymphocyte stimulatory locus (Mls-1a) or staphylococcal enterotoxin B (SEB) expr
Autor:
Paolo Costantino, Rino Rappuoli, Paul-Henri Lambert, Jan D. A. Van Embden, Jacques A. Louis, Ruurd Van Der Zee, Alexander R. Lussow, Christy Barrios, Giuseppe Del Giudice
Publikováno v:
European Journal of Immunology. 22:1365-1372
In a recent work, we have shown that mycobacterial heat-shock proteins (hsp) of 65-kDa (GroEL-type) and 70-kDa (DnaK-type) acted as carrier molecules in mice, previously primed with Mycobacterium tuberculosis var. bovis (bacillus Calmette-Guérin, BC
Publikováno v:
Immunology Letters. 25:255-263
New molecular technologies have accelerated the search for sub-unit candidate vaccines. However, once identified the use of a candidate antigen must be optimised to reap the maximum benefit from the eventual vaccine. This optimisation should take int
Autor:
L Rénia, A S Verdini, J P Verhave, A R Lussow, D Mazier, Paul-Henri Lambert, Pessi A, J A Louis, G. Del Giudice
Publikováno v:
Proceedings of the National Academy of Sciences. 87:2960-2964
Because of its immunodominancy, and because it is conserved in different geographical isolates of Plasmodium falciparum, the repetitive sequence of the circumsporozoite protein, (Asn-Ala-Asn-Pro)n [(NANP)n], has been envisaged for the development of
Publikováno v:
Transplantation. 62(12)
Antihapten antibodies binding to ligand-hapten conjugates are able to mediate complement mediated lysis in vitro. Based on this observation we propose a new in vivo immunotherapy using molecules that combine a low molecular weight hapten binding to a
Publikováno v:
Transplantation proceedings. 28(2)